The Safety and Efficacy of a Single Dose (500 mg or 1 g) of Intravenous Magnesium Sulfate in Neuropathic Pain Poorly Responsive to Strong Opioid Analgesics.

Slides:



Advertisements
Similar presentations
Spinal Cord and Peripheral Nerve Stimulation Techniques for Neuropathic Pain Oscar A. de Leon-Casasola, MD Journal of Pain and Symptom Management Volume.
Advertisements

Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation  Samuel Vokurka, MD, PhD 
Randomized Controlled Pilot Study of Neuromuscular Electrical Stimulation of the Quadriceps in Patients with Non-Small Cell Lung Cancer  Matthew Maddocks,
Chronic Pain Management in Older Adults: Special Considerations
Managing Metastatic Bone Pain: The Role of Bisphosphonates
Neurotoxicity from Chronic Opioid Therapy After Successful Palliative Treatment for Painful Bone Metastases  Andrew Broadbent, BMedSc, MBChB, FRACP, FAChPM,
Is Oxycodone Efficacy Reflected in Serum Concentrations
Managing Metastatic Bone Pain: The Role of Bisphosphonates
Wen Jing Chung, MD, MS, Gregory H. Pharo, DO 
An Assessment of the Safety, Eff icacy, and Acceptability of Intranasal Fentanyl Citrate in the Management of Cancer-Related Breakthrough Pain  Giovambattista.
Effects of High Dose Opioids and Sedatives on Survival in Terminally Ill Cancer Patients  Tatsuya Morita, MD, Junichi Tsunoda, MD, Satoshi Inoue, MD,
Chronic Pain Management in Older Adults: Special Considerations
Opioids for Cancer Breakthrough Pain: A Pilot Study Reporting Patient Assessment of Time to Meaningful Pain Relief  Giovambattista Zeppetella, FRCP  Journal.
Long-Term Opioid Therapy for Chronic Noncancer Pain: A Systematic Review and Meta-Analysis of Efficacy and Safety  Meredith Noble, MS, Stephen J. Tregear,
Managing the Symptoms of Neuropathic Pain: An Exploration of Patients' Experiences  S. José Closs, BSc, RGN, MPhil, PhD, Vicki Staples, BSc, MSc, Innes.
A Phase II Pilot Study to Evaluate Use of Intravenous Lidocaine for Opioid-Refractory Pain in Cancer Patients  Shekhar Sharma, MS, M.R. Rajagopal, MD,
Optimization of opioid therapy for preventing incident pain associated with bone metastases  Sebastiano Mercadante, MD, Patrizia Villari, MD, Patrizia.
A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced.
Randomized Controlled Pilot Study of Neuromuscular Electrical Stimulation of the Quadriceps in Patients with Non-Small Cell Lung Cancer  Matthew Maddocks,
Patient-Controlled Analgesia With Intravenous L-Methadone in a Child With Cancer Pain Refractory to High-Dose Morphine  Rainer Sabatowski, MD, Stefan.
Consistency of Efficacy, Patient Acceptability, and Nasal Tolerability of Fentanyl Pectin Nasal Spray Compared with Immediate-Release Morphine Sulfate.
Use of the Cumulative Proportion of Responders Analysis Graph to Present Pain Data Over a Range of Cut-Off Points: Making Clinical Trial Data More Understandable 
What Influences Patients’ Decisions on Artificial Hydration at the End of Life? A Q- Methodology Study  Catherine Malia, MSc, Michael I. Bennett, MB, ChB,
Combination Analgesic Efficacy
Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation  Samuel Vokurka, MD, PhD 
Cognitive Function Impairment in Patients with Neuropathic Pain Under Standard Conditions of Care  Mónica Povedano, MD, Jordi Gascón, MD, Rafael Gálvez,
Andrew Davies, FRCP, Katherine Webber, PhD 
David M. Dosa, MD, MPH, David D
Nocturnal Hypoxemia in Patients with Cancer
How to Measure the International Development of Palliative Care
Anti-Inflammatories and Heart Failure—Identifying Patients at Risk
An Open-Label, Multi-Dose Efficacy and Safety Study of Intramuscular Tetrodotoxin in Patients with Severe Cancer-Related Pain  Neil A. Hagen, MD, FRCPC,
A Systematic Review Examining the Literature on Attitudes of Patients with Advanced Cancer Toward Research  Anne M.H. Todd, BA (Hons), Barry J.A. Laird,
Acetaminophen (Paracetamol)
David Clark, PhD, Michael Wright, PhD 
Characterization of the early pharmacodynamic profile of oral methadone for cancer- related breakthrough pain: a pilot study  Kim Fisher, PhD, Carla Stiles,
Suresh K Joishy, MD, FACP, Declan Walsh, MSc, FACP 
Paul A. Sloan, MD, Dwight E. Moulin, MD, FRCP(C), Helen Hays, MD 
Cancer patients' share in a population's Use of opioids
Amitriptyline in the Treatment of Chemotherapy-Induced Neuropathic Symptoms  Anna-Liisa Kautio, MD, Maija Haanpää, MD, PhD, Tiina Saarto, MD, PhD, Eija.
Barrie R. Cassileth, PhD, Andrew J. Vickers, PhD 
The Role of a Low-Dose Ketamine-Midazolam Regimen in the Management of Severe Painful Crisis in Patients With Sickle Cell Disease  Qutaiba A. Tawfic,
Efficacy and Side Effects of Diclofenac Patch in Treatment of Patients with Myofascial Pain Syndrome of the Upper Trapezius  Lin-Fen Hsieh, MD, Chang-Zern.
Robert L. Jayes, MD, Robert M. Arnold, MD, Erik K. Fromme, MD 
Prevalence and Characteristics of Breakthrough Pain in Cancer Patients Admitted to a Hospice  Giovambattista Zeppetella, BSc (Hons), MRCGP, Catherine.
Emma Hudson, MRCP, Jason F. Lester, FRCR 
Strategies in Pain Management
Efficacy of intravenous magnesium in neuropathic pain
The Prevalence of Nocturnal Hypoxemia in Advanced Cancer
Methadone Analgesia in Cancer Pain Patients on Chronic Methadone Maintenance Therapy  Paolo L Manfredi, MD, Gilbert R Gonzales, Andrea L Cheville, Craig.
The COX-2 Specific Inhibitor, Valdecoxib, Is An Effective, Opioid-Sparing Analgesic in Patients Undergoing Total Knee Arthroplasty  Lowell W Reynolds,
U.S. Hospice Benefits Journal of Pain and Symptom Management
Papiya Russell, BSc (Med Sci), MBChB, MRCP 
Dylan G. Harris, MBBCh (Hons), MRCP, DipPallMed, Simon I. R
Gabapentin and an Opioid Combination Versus Opioid Alone for the Management of Neuropathic Cancer Pain: A Randomized Open Trial  Kader Keskinbora, MD,
Perceived Success in Addressing End-of-Life Care Needs of Low-Income Elders and Their Families: What Has Family Conflict Got to Do With It?  Betty J.
Ketamine Use for Reduction of Opioid Tolerance in a 5-Year-Old Girl with End-Stage Abdominal Neuroblastoma  Doralina L. Anghelescu, MD, Linda L. Oakes,
James T. Lin, MD, Paul Mathew, MD 
Descriptors of Breathlessness in Patients With Cancer and Other Cardiorespiratory Diseases  Andrew Wilcock, DM, FRCP, Vincent Crosby, MRCGP, Andrew Hughes,
Physical Function in Patients with Cancer
Nina D. Wagner-Johnston, MD, Kathryn A. Carson, ScM, Stuart A
Novel Use of Amantadine: To Treat Hiccups
Long-Term Opioid Therapy for Chronic Noncancer Pain: A Systematic Review and Meta-Analysis of Efficacy and Safety  Meredith Noble, MS, Stephen J. Tregear,
Efficacy and Safety of a Six-Hour Continuous Overlap Method for Converting Intravenous to Transdermal Fentanyl in Cancer Pain  Renato V. Samala, MD, Rafael.
Helping Patients with Advanced Cancer Live with Concerns About Eating: A Challenge for Palliative Care Professionals  Jane Hopkinson, PhD, RGN, Jessica.
The bioavailability of morphine applied topically to cutaneous ulcers
Injected Morphine in Postoperative Pain
Physical Activity Behaviors in Individuals with Multiple Sclerosis: Roles of Overall and Specific Symptoms, and Self-Efficacy  Erin M. Snook, MS, Robert.
Gabapentin as an Adjuvant to Opioid Analgesia for Neuropathic Cancer Pain  Augusto Caraceni, MD, Ernesto Zecca, MD, Cinzia Martini, MD, Franco De Conno,
Papiya B. Russell, BSc, MBChB, MRCP, Sarah C
Presentation transcript:

The Safety and Efficacy of a Single Dose (500 mg or 1 g) of Intravenous Magnesium Sulfate in Neuropathic Pain Poorly Responsive to Strong Opioid Analgesics in Patients with Cancer  Vincent Crosby, MRCGP, Andrew Wilcock, Dm Mrcp, Ray Corcoran, FRCOG  Journal of Pain and Symptom Management  Volume 19, Issue 1, Pages 35-39 (January 2000) DOI: 10.1016/S0885-3924(99)00135-9

Fig. 1 Mean (SEM) pain intensity and pain relief scores for 500 mg and 1 g of intravenous magnesium sulfate Journal of Pain and Symptom Management 2000 19, 35-39DOI: (10.1016/S0885-3924(99)00135-9)